know the enemy
“Every day, two full classrooms of kids are diagnosed with cancer.”
While doctors and researchers have made strides in the battle against so many other types of cancer, the lack of funding and awareness for our children has led to an insignificant improvement in survival rates for pediatric cancer over the past decade. As a result, cancer continues to be the number one disease killer of children in our country, more than asthma, diabetes, cystic fibrosis and pediatric AIDS combined! We need your continued help to raise more funds and more awareness.
Letter from John Maris, Children’s Hospital of Philadelphia
- The Press On Foundation provided us with the essential funding required to bridge the gap of an important new discovery of why children develop neuroblastoma into a new $3.3 million dollar NIH grant to study how to use this information to make smarter therapies.
- The Press On Foundation invested in a completely new idea to make a more effective and less toxic form of “systemic radiation therapy”. Many patients with neuroblastoma currently benefit from a treatment using a radioactive drug called MIBG, but it is not in and of itself curative. Our group used seed funding from Press On to make a new drug that is 1000 times more potent, and allowed us to receive a large grant from the government to make this into a drug deliverable to children.
- The impact on the Press On Foundation on the next generation of pediatric cancer scientists can not be underestimated. In my own program, Press On funding directly impacted the career development of three promising young investigators, each of whom have new major publications and/or grants to further there career.
In each of these examples I think you can emphasize the multiplicative effect of your funding, and emphasize that there are many more examples at other institutions.
John M. Maris, MD
Giulio D’Angio Endowed Professor of Pediatrics
Children’s Hospital of Philadelphia
Perelman School of Medicine at the University of Pennsylvania